Thank you, Dr. Ramon Bataller, for spotlighting our work. Our study shows that #MetALD carries a higher risk of cancer mortality compared to MASLD. Interesting study led by Majd Aboona, MD Journal of Gastroenterology and Hepatology Karn Wijarnpreecha Juan Pablo (JP) Arab, MD  Mazen Noureddin, MD, MHSc Naim Alkhouri

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma | Nature Communications. Interesting article on Lenvatinib nature.com/articles/s4146…

#HCC #livertwitter #MedEd 🎀Role of temporary #portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome 🧑‍🎓Team: Jacopo Lanari Padua University Hospital,Italy. 👉To learn more, please visit: f.oaes.cc/xmlpdf/74689a4…

#HCC #livertwitter #MedEd 🚀Dysmetabolic comorbidities and #non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-#associated steatotic liver disease 💥Ludovico Abenavoli University “Magna Graecia” of Catanzaro,Italy. 📕More: f.oaes.cc/xmlpdf/054d92d…

#HCC #livertwitter #MedEd 💥Precise staging of advanced HCC promotes higher quality of personalized treatment management: Chinese experts consensus on #precision diagnosis and management of advanced hepatocellular carcinoma (2023) 📝More: f.oaes.cc/xmlpdf/ab0d7c2…

#HCC #livertwitter #MedEd 🎀Role of temporary #portosystemic surgical shunt during liver resection to prevent a #post-resection small for size-like syndrome 👉To learn more, please visit: f.oaes.cc/xmlpdf/2877478… 🌞Welcome to read and share it within your network!

👏 👏 Stay up to date with upcoming webinar "#Liver #Transplantation for #HCC: #Indication Criteria and #Perioperative Risk Factors for Survival" on September 12, 2024. 👨‍⚕️ Chair: Dr. Giuliano Ramadori and Dr. Umberto Cillo Umberto Cillo ✔ Register: oaepublish.com/webreviewer/hr…

#HCC #livertwitter It is such a pleasure to bridge this wonderful platform for researchers to communicate, share and sparks new ideas. Veronica Loy Manal Abdelmalek Vinay Sundaram, MD, MSc Matteo Ravaioli Oren Fix Hashem el- Serag Karim J Halazun MD Ali Zarrinpar Joel P Wedd MD, MPH Debbie Shawcross

#CCA #livertwitter #MedEd 🎀Mutation-based therapies for #intrahepatic cholangiocarcinoma: new options on the horizon 💐mutation-based therapy 💐precision medicine 💥To learn more, please visit: f.oaes.cc/xmlpdf/ba5d08a…

🌟 The webinar “Liver Fibrosis in Metabolic Dysfunction” successfully concluded on August 22nd! 📅🎉 👉 Click here to watch the recorded video: oaepublish.com/webinars/mtod.… #livertwitter

📢 📢 Attention! It's not too late to register: oaepublish.com/webinars/hr.283 Nik Mazumder Abdul Hakeem PhD, FRCS Archita Desai Martina Gambato Manuel Luis Rodríguez Perálvarez Marco Claasen Elton Dajti Alejandro Pita Chandra bhati Dominik Bettinger Kristopher Croome Graciela Castro Narro Ali Wakil, MD Leonardo Centonze Ajay Duseja

#HCC #livertwitter #MedEd 🚀Racial, ethnic, and #socioeconomic differences in hepatocellular carcinoma across the United States 💥Team: Timothy M. Pawlik, The Ohio State University, USA. 🌞More: f.oaes.cc/xmlpdf/f21797f…

#HCC #livertwitter #MedEd 💥Is the Mediterranean diet a good preventive measure for #NASH? 🎯Ludovico Abenavoli, University “Magna Graecia” of Catanzaro, Italy. 🌞To learn more, please visit: f.oaes.cc/xmlpdf/2bcb96c…

#liver cancer #livertwitter #MedEd 🎯Introduction of Chinese expert consensus on neoadjuvant therapy for #primary liver cancer (2023 edition) 📝To learn more, please visit: f.oaes.cc/xmlpdf/cf528fd… 🌞Welcome to read and share. Hope it brings some inspiration to your work！

#CCA #livertwitter #MedEd 🎯Crosstalk between #cancer cell plasticity and immune microenvironment in cholangiocarcinoma 🌟Team: Laura Fouassier Sorbonne Université,Paris, France. 📝More: f.oaes.cc/xmlpdf/08c3496…

#liver cancer #livertwitter #MedEd 💥Associations between #physical activity and risk of liver cancer: results from a population-based cohort study in Chinese women 👉To learn more, please visit: f.oaes.cc/xmlpdf/73241dc… 👏Welcome to read and share.

👏 👏 Stay up to date with upcoming webinar "#Liver #Transplantation for #HCC: #Indication Criteria and #Perioperative Risk Factors for Survival" on September 12, 2024. 👨‍⚕️Chair: Dr. Giuliano Ramadori and Dr. Umberto Cillo Giuliano Ramadori Umberto Cillo 👉Register:oaepublish.com/webreviewer/hr…

#HCC #livertwitter #MedEd 💥Glioma-associated oncogene (GLI)-specific decoy oligodeoxynucleotide induces apoptosis and attenuates proliferation, colony formation, and migration in #liver cancer cells 🌞Team: Meenal Datta 📝More : f.oaes.cc/xmlpdf/1d0859a…

#HCC #livercancer #livertwitter #MedEd Don't miss the excellent opportunity to communicate with our remarkable speakers! Register: oaepublish.com/webreviewer/hr… Ali Wakil, MD DrManishaBangar Palak Trivedi Nadim Mahmud Adam Winters Russell Rosenblatt Avash Kalra, MD Jon Potts

#HCC #LiverTransplantation #webinar 🌟Would you like to hear more about the latest advancements in liver transplantation for HCC? 👏Join us for an insightful webinar! 👉Register now: oaepublish.com/webreviewer/hr…